Researchers find that blocking specific proteins in immune cells can reduce or reverse lung scarring

Updated on: April 19,2025 0

Researchers find that blocking specific proteins in immune cells can reduce or reverse lung scarring

Updated on:April 19,2025 0

AI-designed spatial gene map identifies early markers of idiopathic pulmonary fibrosis

Updated on: April 18,2025 0

AI-designed spatial gene map identifies early markers of idiopathic pulmonary fibrosis

Updated on:April 18,2025 0

What is 'double pneumonia,' the condition that has put Pope Francis in hospital?

Updated on: April 02,2025 0

What is 'double pneumonia,' the condition that has put Pope Francis in hospital?

Updated on:April 02,2025 0

Common bacterial infection may trigger lung transplant rejection

by Bob Yirka , Medical XpressPseudomonas-induced antibody-mediated rejection of lung allografts in mice. Credit:Science Translational Medicine(2025). DOI: 10.1126/scitranslmed.adu6563A lar

Updated on: February 20,2025 0

Common bacterial infection may trigger lung transplant rejection

by Bob Yirka , Medical XpressPseudomonas-induced antibody-mediated rejection of lung allografts in mice. Credit:Science Translational Medicine(2025). DOI: 10.1126/scitranslmed.adu6563A lar

Updated on:February 20,2025 0

High-flow nasal oxygen noninferior to noninvasive ventilation for acute respiratory failure

High-flow nasal oxygen noninferior to noninvasive ventilation for acute respiratory failureby Lori SolomonHigh-flow nasal oxygen (HFNO) is noninferior to noninvasive ventilation (NIV) for endotracheal

Updated on: January 19,2025 0

High-flow nasal oxygen noninferior to noninvasive ventilation for acute respiratory failure

High-flow nasal oxygen noninferior to noninvasive ventilation for acute respiratory failureby Lori SolomonHigh-flow nasal oxygen (HFNO) is noninferior to noninvasive ventilation (NIV) for endotracheal

Updated on:January 19,2025 0

Common cough syrup ingredient offers hope for lung fibrosis patients

by Andreia Pinho,European Molecular Biology LaboratoryA new study has explored the potential of Dextromethorphan, an FDA-approved drug, in the treatment of lung fibrosis. Lung fibrosis occurs af

Updated on: January 17,2025 0

Common cough syrup ingredient offers hope for lung fibrosis patients

by Andreia Pinho,European Molecular Biology LaboratoryA new study has explored the potential of Dextromethorphan, an FDA-approved drug, in the treatment of lung fibrosis. Lung fibrosis occurs af

Updated on:January 17,2025 0

Weekly Update of Drug News-8/1/2025

Updated on: January 08,2025 0

Weekly Update of Drug News-8/1/2025

Updated on:January 08,2025 0

Patient perspectives central for developing new therapies for COPD

by COPD FoundationThe mechanistic model is a logical link between patient-inspired health concepts, a drug's mechanism of action, and subset of measures selected to test and communicate product-sp

Updated on: December 22,2024 0

Patient perspectives central for developing new therapies for COPD

by COPD FoundationThe mechanistic model is a logical link between patient-inspired health concepts, a drug's mechanism of action, and subset of measures selected to test and communicate product-sp

Updated on:December 22,2024 0

WHO Announces First Prequalification of a Tuberculosis Diagnostic Test

The World Health Organization (WHO) has granted prequalification to the molecular diagnostic test for tuberculosis (TB) called Xpert® MTB/RIF Ultra. This is the first test for TB diagnosis and antibiotic susceptibility testing that meets WHO's prequalific

Updated on: December 10,2024 0

WHO Announces First Prequalification of a Tuberculosis Diagnostic Test

The World Health Organization (WHO) has granted prequalification to the molecular diagnostic test for tuberculosis (TB) called Xpert® MTB/RIF Ultra. This is the first test for TB diagnosis and antibiotic susceptibility testing that meets WHO's prequalific

Updated on:December 10,2024 0

Conversations between pharmacists and patients reveal factors behind pneumococcal vaccine hesitancy

by Adrianna MacPherson,University of AlbertaCredit: CC0 Public DomainResearchers at the University of Alberta looked at conversations between pharmacists and patients before and after an educati

Updated on: December 05,2024 0

Conversations between pharmacists and patients reveal factors behind pneumococcal vaccine hesitancy

by Adrianna MacPherson,University of AlbertaCredit: CC0 Public DomainResearchers at the University of Alberta looked at conversations between pharmacists and patients before and after an educati

Updated on:December 05,2024 0

Study examines development of early COPD in ages 30 to 55

by COPD FoundationDistribution of Forced Expiratory Volume in 1 Second Trajectory from COPD Cohort Studies, Based on Presence or Absence of GOLD Grade ≥2 at the Final Exam. Credit:Chronic Obstru

Updated on: November 30,2024 0

Study examines development of early COPD in ages 30 to 55

by COPD FoundationDistribution of Forced Expiratory Volume in 1 Second Trajectory from COPD Cohort Studies, Based on Presence or Absence of GOLD Grade ≥2 at the Final Exam. Credit:Chronic Obstru

Updated on:November 30,2024 0

Basic research leads to drug candidates for fatal lung disease

by Åsa Malmberg,Uppsala UniversityAnders Hallberg follows the work in the lab with interest. To his right is Marcus Söderström. Credit: Mikael WallerstedtDuring the 1990s, medicinal chemist Ande

Updated on: November 30,2024 0

Basic research leads to drug candidates for fatal lung disease

by Åsa Malmberg,Uppsala UniversityAnders Hallberg follows the work in the lab with interest. To his right is Marcus Söderström. Credit: Mikael WallerstedtDuring the 1990s, medicinal chemist Ande

Updated on:November 30,2024 0